IOT.V 0.08 0.00 0.00%
  • |
Contact Us

News

Innovotech Inc. Receives Support to Develop Antimicrobial Testing Services and Product Enhancements

Innovotech Inc. Reports Q1 2026 Financial Results and Operational Update 

Interim Financial Statements & MD&A for period ended 31 March 2026

Annual General and Special Meeting of Shareholders – Innovotech Inc. 2026

Up to 80% of microbial infections involve biofilms, which can be 10 to 1,000× more tolerant to antibiotics than their free-floating counterparts.

FendX Engages Innovotech for Regulatory Pathway Assessment of Its Coated Foley Catheter Program

Innovotech Inc. Begins Trading on OTCQB Under Symbol IOTCF, Expanding Access for U.S. Investors

Innovotech Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results

Consolidated Financial Statements and MD&A for December 31, 2025 and 2024

See you at the CSHP Banff Seminar

CSHP Banff Seminar

Innovotech Inc. Strengthens Executive Team and Announces New Edmonton Facility Lease